4D Molecular Therapeutics Inc (FDMT)
7.99
-0.42
(-4.99%)
USD |
NASDAQ |
Nov 21, 16:00
7.975
-0.02
(-0.19%)
Pre-Market: 20:00
4D Molecular Therapeutics Shareholders Equity (Quarterly): 552.95M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 552.95M |
| June 30, 2024 | 588.34M |
| March 31, 2024 | 600.56M |
| December 31, 2023 | 307.83M |
| September 30, 2023 | 329.93M |
| June 30, 2023 | 325.14M |
| March 31, 2023 | 218.61M |
| December 31, 2022 | 231.34M |
| September 30, 2022 | 251.44M |
| June 30, 2022 | 272.52M |
| Date | Value |
|---|---|
| March 31, 2022 | 296.06M |
| December 31, 2021 | 319.11M |
| September 30, 2021 | 224.13M |
| June 30, 2021 | 240.65M |
| March 31, 2021 | 242.43M |
| December 31, 2020 | 256.39M |
| September 30, 2020 | 70.16M |
| December 31, 2019 | -72.97M |
| June 30, 2019 | -42.30M |
| December 31, 2018 | -27.59M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-72.97M
Minimum
Dec 2019
600.56M
Maximum
Mar 2024
291.92M
Average
264.45M
Median
Shareholders Equity (Quarterly) Benchmarks
| Regeneron Pharmaceuticals Inc | 29.33B |
| Ocular Therapeutix Inc | 352.02M |
| NovaBay Pharmaceuticals Inc | 1.072M |
| Palatin Technologies Inc | -7.686M |
| iBio Inc | 17.75M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 604.03M |
| Total Liabilities (Quarterly) | 51.08M |
| Current Ratio | 17.33 |